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ABSTRACT OF THESIS 
 
 
 
 
INFLUENCE OF TISSUE ABSORPTION AND SCATTERING ON 
DIFFUSE CORRELATION SPECTROSCOPY BLOOD FLOW MEASUREMENTS 
 
This investigation evaluates the influences of optical property assumptions on near-
infrared diffuse correlation spectroscopy (DCS) flow index measurements. Independent 
variation is induced in optical properties, absorption coefficient (μa) and reduced 
scattering coefficient (μs’), of liquid phantoms with concurrent measurements of flow 
indices. A hybrid instrument is incorporated consisting of a dual-wavelength (785 and 
830 nm) DCS flow device to obtain flow indices and a frequency-domain tissue-oximeter 
for optical properties. Flow indices are calculated with measured μa and μs’ or assumed 
constant μa and μs’. Inaccurate μs’ assumptions produced much larger flow index errors 
than inaccurate μa. Underestimated/overestimated μs’ from -35%/+175% lead to flow 
index errors of +110%/-80% and underestimated/overestimated μa from -40%/+150% 
lead to -20%/+40%, regardless of wavelength. Analysis of a clinical study involving 
human head and neck tumors indicates flow index errors due to inter-patient optical 
property variations up to +280%. Collectively, these findings suggest that studies 
involving significant μa and μs’ changes should measure flow index and optical properties 
simultaneously to accurately extract blood flow information. This study provides unique 
insight through the use of liquid phantoms, hybrid instrumentation, incorporation of 
measurement errors and a generalization into DCS flow index errors due to the influences 
of optical properties. 
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α  Ratio of Moving Scatterers to Total Scatterers 
αDB  Effective Diffusion Coefficient 
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2
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CHAPTER 1: INTRODUCTION 
 
1.1 Blood Flow Measurements 
Blood flow is widely used as a physiological parameter in the assessment of multiple 
facets of disease including diagnosis [1] and treatment efficacies [2]. Analyses of blood 
flow extend into many applications. For example, the identification of blood flow 
abnormalities may be investigated for diseases such as peripheral arterial disease (PAD) 
[3]. The increase or decrease of blood flow to ischemic muscle tissue after surgical 
techniques can provide useful information as to the success of the procedures [3]. 
Monitoring blood flow may reveal benefits of particular treatment methods which are 
very important in studies involving tumors [1, 2, 4]. The tumor blood flow response to 
applications of radiation treatment to subjects with tumors can reveal if the treatment is 
working [2, 4]. The tumor site may also potentially be identified through exhibition of 
blood flow different from that of surrounding tissues [1]. Blood flow responses may also 
be followed after induced stimuli to examine activity of the brain [5].  
In practice, blood flow measurements can be achieved through a variety of 
noninvasive technologies. Each has their own advantages and disadvantages and thus 
many factors must be considered including costs, portability, subject anatomy, accuracy, 
data acquisition time, and sensitivity. Sensitivity concerns the differentiation between 
vessels of varying sizes from large, such as arteries, to small such as capillaries. For 
superficial blood flow measurements (several μm to mm), technologies such as laser 
Doppler flowmetry (LDF) [6-8], optical microangiography (OMAG) [9], Doppler optical 
coherence tomography (DOCT) [10], and photoacoustic tomography (PAT) [11] may be 
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utilized. Penetration into deep tissues (e.g., several centimeters) is a limitation of 
employing these methods. Several modalities exist capable of penetrating into deep 
tissues such as Xenon-enhanced computed tomography (Xe-CT) and positron emission 
tomography (PET). While these are predominantly sensitive to microvasculature, they 
require the need for undesirable exposure to effects such as radiation. The applicability of 
using these deep penetration devices bedside is limited due to high costs and low 
portability. A new technology, near-infrared (NIR) diffuse correlation spectroscopy 
(DCS), has sought to fill some of the gaps in deep tissue microvasculature blood flow 
measurements by means of low cost, noninvasive, fast and portable instrumentation. 
 
1.2 Near Infrared Diffuse Optical Techniques 
Our investigations involve the use of NIR light to probe deep tissues. NIR light is 
employed in biomedical applications due to the discovery of a spectral (600 – 900 nm) 
window (see Fig. 1) in biological tissues [12]. This window allows deep penetration due 
to the low tissue absorption. Diffuse optical systems can be utilized for the extraction of 
information including tissue optical properties, oxygenated hemoglobin concentration 
(HbO2), deoxygenated hemoglobin concentration (Hb), and blood flow [12, 13]. Note 
that tissue optical properties are represented by the absorption coefficient, μa (cm-1 units), 
and reduced scattering coefficient, μs’ (cm-1 units). We will refer to diffuse optical 
equipment measuring μa, μs’, HbO2, and Hb as NIR spectroscopy (NIRS) and blood flow 
as DCS. 
Typically, NIRS is separated into three paradigms: time-domain (TD) (additionally 
known as time-resolved spectroscopy, TRS), frequency-domain (FD), and continuous-
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wave (CW). TD systems use light pulses and contain high information content but are 
expensive and complex [12, 13]. Modulated light from FD systems provide less 
information content than TD systems but are capable of separating μa and μs’ and 
obtaining Hb and HbO2 [12, 13]. The final paradigm employs a CW light source and is 
generally inexpensive and simple in comparison to the TD and FD paradigms. However, 
CW light provides limited information content making it difficult to decouple tissue 
optical properties [12, 13]. In this study we are only concerned with absolute μa and μs’ 
from FD NIRS measurements. 
 
 
Figure 1. Spectral Window 
The wavelength-dependent absorption coefficients (μa) shown for oxygenated hemoglobin (HbO2), 
deoxygenated hemoglobin (Hb), and water (H2O) with the NIR spectral window denoted with dashed lines 
for the wavelength range of 600 – 900 nm. 
 
For NIRS measurements, a pair of source and detector optical fibers is placed on the 
tissue surface separated by a distance of up to a few centimeters. An NIR laser emits light 
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into tissue through the source fiber. Photon migrates in the tissue following a well-known 
diffusive process before being detected by a photodetector connected to the detector fiber 
[12, 14]. The tissue optical properties, μa and μs’, represent the reciprocals of absorption 
and scattering length, respectively. The absorption length describes the distance a photon 
travels before encountering an absorption event and similarly for the scattering length 
corresponding to a scattering event. Note that the optical properties are wavelength, λ, 
dependent, i.e., μa (λ) and μs’ (λ), but are written without the dependence notation 
throughout this paper. Light scattering in biological tissues is generally much greater than 
that of absorption resulting in diffusive behavior. 
For the determination of particle dynamics (flow), speckle fluctuations in scattered 
light intensity are monitored [12, 13]. Previous success in flow measurements (e.g., laser 
Doppler) has been obtained in optically thin samples where single scattering photon 
correlation spectroscopy (PCS) can be assumed [13, 15, 16]. In probing the motions in 
thick/deep tissues, however, additional complications are encountered. Such optically 
thick tissue samples result in multiple scattering and randomization of light propagation. 
To address this multiple scattering problem DCS [14, 15, 17, 18], also known as diffusing 
wave spectroscopy (DWS) [5, 19], has been developed that takes advantage of the 
diffusive behavior of light as it propagates through the tissue. 
 
1.3 Diffuse Correlation Spectroscopy (DCS) 
DCS flow measurements are performed from the surface of the tissue region of 
interest, similar to NIRS. The flow measurements are obtained by monitoring the time 
autocorrelation function of speckle fluctuations detected at the photodetector. To 
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accomplish this, a long coherence length CW NIR laser is employed to provide a constant 
phase both spatially and temporally [12, 14, 16]. Speckle fluctuations in non-muscular 
biological tissues are primarily due to the movement of red blood cells (RBC’s) in vessels 
[1, 2, 4, 5, 12, 18, 20-38]. However, motion artifacts and tissue shearing may arise in 
muscular tissues which may complicate measurements [39, 40]. DCS produces a blood 
flow index (BFI) and subsequent relative blood flow (rBF) from those fluctuations. The 
rBF produced from DCS measurements has been validated against other technologies in 
many tissues. These include comparisons with Xe-CT [23], Doppler ultrasound [20, 21], 
LDF [12], power Doppler ultrasound [4, 22], arterial spin labeled magnetic resonance 
imaging (ASL-MRI) [25, 41], fluorescent microsphere measurements [24], and to 
literatures [17, 18, 26, 27, 42]. DCS systems have had their usage expanded into many 
deep tissue applications including brain [5, 12, 18, 20, 21, 23-27, 29, 33-37], muscle [3, 
39-41, 43, 44], and tumor [1, 2, 4, 22, 28, 30-32]. 
DCS can be made simple, inexpensive, and portable with short acquisition times 
(from 6.5 ms up to several seconds) such that bedside monitoring is made feasible [1, 27, 
29, 39]. DCS is sensitive predominantly to microvasculature instead of the larger blood 
vessels. An inherent feature to using optical modalities is the noninvasive nature of 
measurements without the need for imposing undesirable effects such as radiation 
exposure. Spatial resolution is relatively low (~cm) governed by the volume probed 
where the penetration depth is approximately half of the separation between source and 
detector fibers. Thus, DCS fills a unique niche with the ability to simply and quickly 
monitor blood flow in deep tissues with robust applicability. 
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1.4 DCS Measurement Limitations and Current Study 
Within the DCS theoretical framework, the BFI calculation has a dependence on 
tissue properties, μa and μs’. Thus, calculations in the DCS flow indices will be 
influenced by variations in these optical properties (see details in Chapter 2.1). An 
additional potential influence on the flow indices is the laser source wavelength chosen. 
As DCS requires a CW light source it is inherently incapable of monitoring absolute 
tissue optical properties during flow acquisition. Two general methods commonly serve 
as solutions to this dilemma: using separate instrumentation for monitoring the optical 
properties or making assumptions of their values. In some recent studies, hybrid 
instrumentation has been used to monitor both sets of information in order to establish 
accurate blood flow data [1, 2, 21, 39, 45]. This method may be costly or unavailable and 
in such cases requires making assumptions as to the optical properties of the particular 
tissue being investigated. In studies where assumptions in optical properties are made 
typically either the μs’ is assumed constant while μa changes are measured [24, 36, 43] or 
the values for both μa and μs’ are obtained from literatures for the respective tissue type 
(e.g., brain or tumor) [20, 40]. However, by making optical property assumptions there 
will be an increased susceptibility to longitudinal, transient, and inter-subject deviations 
from the assumed values or differences between literatures. 
Another concern is that flow indices in DCS tissue measurements actually correspond 
to a calculated effective Brownian diffusion coefficient (see Chapter 2.1). This diffusion 
coefficient is considered to be different from the conventional Brownian diffusion 
coefficient as predicted by Einstein [46]. It has been determined empirically that dynamic 
scatterer motions (typically microvasculature RBC’s) are best modeled by Brownian 
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diffusion rather than random ballistic flow, but the reasons for this are currently unknown 
[4, 12, 18, 20, 22, 28, 29, 36]. Thus, there is a lacking in some standard of comparison for 
the DCS flow index. 
Currently, there has been no known generalization of potential DCS BFI errors due to 
inaccuracies in the estimation of the optical properties. A formal study is needed to 
elucidate upon the lack of optical property data while making DCS blood flow 
measurements. We have recently built a hybrid instrument in our lab capable of 
measuring flow indices using DCS and absolute μa and μs’ using NIRS at several 
wavelengths simultaneously [44]. With this hybrid instrument we now have the capacity 
to evaluate and quantify optical property influences on DCS flow indices at different 
wavelengths. The FD NIRS system is incorporated to obtain the absolute μa and μs’ at 
multiple wavelengths. These tissue optical properties are extracted from the modulated 
light AC, DC, and Phase information as it passes through the sample.  
We have created homogeneous liquid phantoms allowing for manipulation of the 
optical property variations. NIRS and DCS techniques commonly employ liquid 
phantoms to emulate tissue for experimental and calibration purposes [13, 14, 18, 47-53]. 
Each parameter, either μa or μs’, are varied individually to isolate their respective 
influence on DCS flow indices. By using liquid phantoms a standard for comparison with 
DCS is now possible. The phantoms include spherical particles suspended in liquid and 
undergoing Brownian motion as modeled by Einstein. Contrary to tissue, DCS 
measurements on these liquid phantoms should produce effective Brownian diffusion 
coefficients (i.e., DCS flow indices) which are now equivalent to the Einstein predictions. 
By utilizing this situation, the Brownian diffusion coefficient found using the Einstein-
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Stokes formula [46] can be considered a true flow index. This can subsequently be used 
in comparison to DCS flow indices calculated using assumed or measured optical 
properties. Errors can then be determined in DCS flow indices due to the inaccurate 
optical property estimations at multiple wavelengths. 
This study resolves the need for combining instrumentation to monitor both blood 
flow using DCS technology simultaneously with acquisition of tissue optical properties. 
We utilize liquid phantoms as a valuable means to investigate the influences of these 
optical properties on DCS flow indices. In addition, through comparisons of DCS flow 
indices with Brownian diffusion coefficients (true flow indices) we are capable of 
quantifying measurement errors in our system and methods. To further investigate the 
implications of the phantom study, a clinical study performed with the hybrid instrument 
for monitoring blood flow indices and optical properties of head and neck tumors is 
analyzed. Determination of in-vivo applicability involves ascertaining the measurement 
errors in tumor blood flow indices which are discussed and compared to the phantom 
study findings. 
This thesis is organized into the following chapters. Chapter 2 opens with discussion 
of the theory used in DCS BFI calculations along with a brief overview of absolute μa and 
μs’ measurements and hybrid instrument operation. Details pertaining to Brownian 
motion and liquid phantoms are also provided. The experimental protocols and methods 
of data analysis for the phantom study and in-vivo tumor study complete the chapter. The 
results of the phantom experiments and tumor study analysis are detailed in Chapter 3 
with respective discussion and conclusions in Chapter 4. Finally, Chapter 5 presents the 
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novel contributions in this study along with directions for future research and 
investigations. 
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CHAPTER 2: METHODS AND MATERIALS 
 
A hybrid NIR diffuse optical instrument combining a commercial frequency-domain 
NIR tissue-oximeter, the Imagent (ISS, Inc., IL, USA) [47, 48], and a custom-made NIR 
DCS flow-oximeter [3, 37, 44] was used in this study for simultaneous measurements of 
tissue optical properties and flow indices (see Fig. 2). The influences of optical properties 
on blood flow indices were examined in liquid phantoms with varied optical properties 
and in head and neck tumors using hybrid optical instruments. This chapter is organized 
as follows. First, the theories involved in obtaining DCS flow indices (i.e., effective 
Brownian diffusion coefficients) (Chapter 2.1) and tissue optical properties (i.e., μa and 
μs’) (Chapter 2.2) are introduced along with the hybrid instrument data acquisition details 
(Chapter 2.3). Afterwards, the manner of determining Brownian diffusion coefficients 
(Chapter 2.4) is described. Next, the methods used for creating the liquid phantoms with 
varied optical properties are given (Chapter 2.5). Following is a discussion of the 
experimental protocols (Chapter 2.6) and data analysis (Chapter 2.7) in liquid phantoms. 
Finally, particulars concerning an analysis of real tissue data in a clinical study of head 
and neck tumors are provided (Chapter 2.8). 
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Figure 2. Hybrid Instrument 
The combined Imagent and DCS hybrid instrument used during the phantom study with: (a) hybrid optical 
probe, (b) DCS flow-oximeter with 2 multi-mode laser source fibers (200 µm diameter) bundled together 
(785 and 830 nm) at 1.5 cm separation from 4 single-mode detector fibers (5.6 µm diameter) bundled 
together, (c) Imagent with 8 laser source fibers arranged as 1 per each wavelength at 4 separations (2.0, 2.5, 
3.0, and 3.5 cm) of 780 and 830 nm along with 1 detector fiber, and (d) hybrid instrument. Note that two 
additional DCS detector fibers are shown, at 2.4 and 2.8 cm separations, but were not connected for this 
study. 
 
2.1 Diffuse Correlation Spectroscopy (DCS) for Blood Flow Measurements 
The dual-wavelength DCS system [44] with two long coherence length CW NIR laser 
sources at 785 and 830 nm (100 mW, Crystalaser, Inc., NV, USA) is used to quantify 
DCS flow indices from measurements on turbid samples such as biological tissues and 
liquid phantoms. DCS laser light is emitted into the tissue alternately by means of two 
multi-mode optical fibers (200 µm diameter). These fibers are bundled together on the 
tissue surface at the same position (see Fig. 2). Four single-mode detector fibers (5.6 µm 
diameter) are bundled and placed on the tissue surface as well with 1.5 cm separation 
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from the source fiber bundle, combined into a rectangular foam pad. Each detector fiber 
is connected to a single photon-counting avalanche photodiode (APD) (PerkinElmer, 
Inc., Canada). A 4-channel autocorrelator board (Correlator.com, NJ, USA) receives the 
outputs of the 4 APDs and produces normalized light intensity temporal autocorrelation 
functions (g2). The g2’s from four detectors are averaged to improve the signal-noise-ratio 
(SNR). The averaged g2 can then be related to the normalized electric field temporal 
autocorrelation function (g1) through the Siegert relation [54], 
 ( ) ( ) 212 ,rg1,rg τβ+=τ rr  (1) 
where τ is the delay time, rr  is the position vector, and β depends on laser stability and 
coherence length and the number of speckles detected. 
Although in practice DCS measures g2, the analytical solution is for g1 derived from 
the transport of the unnormalized temporal electric field correlation function (G1) through 
the turbid sample. The moving scatterers will contribute to the exponential decay of G1. 
The transport of G1 results in the following correlation diffusion equation, derived 
rigorously elsewhere [13, 14], for homogeneous media with a CW source (steady state):  
 ( ) ( ) )r(vS,rGrkv
3
1vD 1
22
0
'
sa
2 rr −=τ⎟⎠
⎞⎜⎝
⎛ τΔαμ−μ−∇  (2) 
where )3/(vD 'sμ=  is the photon diffusion coefficient, v is the speed of light in the 
medium, 20k  is the wavenumber, )r(S
r  is the source light distribution, and ( )τΔ 2r  is the 
mean-square displacement of scatterers in time τ. The position vector, rr , denotes a 
general vector from a source to a point of detection. Notice that g1 is the normalized form 
of G1, as used in Eq. 1, i.e., ( ) ( ) ( )0,rG/,rG,rg 111 rrr τ=τ . 
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The homogeneous CW solution to Eq. 2 for semi-infinite geometry is (see Fig. 3): 
 ( ) ( )( ) ( )( )⎟⎟⎠
⎞
⎜⎜⎝
⎛ τ−−τ−π=τρ 2
2
1
10
1 r
rKexp
r
rKexp
D4
vS,G  (3) 
where S0 is the source intensity, ρ is the separation distance between source and detector, 
( ) ( )τΔαμ+μμ=τ 2202's'sa2 rk3K , ( )[ ] 2/12021 zzr −+ρ= , ( )[ ] 2/12b022 zzzr 2+++ρ= , 's0 /1z μ= , 
( ) ( )eff'seffb R13/R12z −μ+= , n0636.0668.0n710.0n440.1R 12eff +++−= −− , and n ≈ 1.33 
(for phantoms and tissues) [12, 13, 55, 56]. The Reff term accounts for the mismatch 
between the medium and air index of refraction with n being the ratio between them. 
The collimating laser source is placed at (0, 0, 0) and detector at (ρ, 0, 0) on the tissue 
surface with z = 0 (see Fig. 3) for semi-infinite geometry. The solution (Eq. 3) involves 
an isotropic source at z = z0 and negative isotropic imaging source at z = -(z0 + 2zb) with 
an extrapolated zero boundary condition. The position vector, rr , from Eq. 2 regards the 
point source at (0, 0, z0) and negative imaging source at (0, 0, -(z0 + 2zb)). The 
superposition of solutions to these two sources with infinite geometry provides the 
resulting Eq. 3 where now the semi-infinite boundary is modeled by the scalar parameter, 
ρ. Further details are given elsewhere [13, 56].  
The movement of scatterer particles is typically characterized for biological tissues by 
Brownian motion with ( ) τ=τΔ B2 D6r , where DB is the effective Brownian diffusion 
coefficient. In order to differentiate static and dynamic scatterer particles, an α (0 – 1) 
term is added. This term is defined as the ratio of dynamic to total scatterers from the 
sample. The BFI produced by DCS in tissues is defined as the combined dynamic 
scatterer ratio with the effective Brownian diffusion coefficient, i.e., αDB. The BFI can 
then be used to determine the rBF by comparison with the baseline BFI, BFIBaseline, prior 
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to any physiological changes, i.e., BaselineBFI/BFIrBF = . In tissue samples, scatterers 
may be static (e.g., mitochondria, organelle) or dynamic (RBC). However, in liquid 
phantom solutions (see Chapter 2.5) all scatterers are dynamic resulting in α ≈ 1. Thus, 
the DCS flow indices in this thesis related to the phantom study are reported as just DB. 
 
 
The process of DCS data acquisition beginning with tissue measurement (bottom left) and ending with 
(bottom right) production of a DCS flow index (αDB). Cartesian coordinates are shown with respect to DCS 
source-detector and tissue orientation with the y-axis directed into the page. A typical correlation curve is 
shown as an example, taken from a phantom experiment (μa (830 nm) = 0.05 cm-1, μs’ (830 nm) = 10 cm-1) 
with g1 derived from g2 measurements (g1m) using Eq. 1 and g1 calculated (g1c) using Eq. 3. 
 
To quantify a flow index, ),r(g 2 τr  is first obtained for a given sampling time (~44 
ms) from the correlator where the sample is illuminated by a DCS source (either 785 or 
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  Figure 3. DCS Data Acquisition
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830 nm). Multiple samples are obtained and averaged during a measuring time of ~1.2 s. 
From Eq. 1, β is found at τ ≈ 0 using measured )0,(g2 ρ  and 1)0,(g1 ≈ρ  (i.e., 
( ) ( ) ( ) 10,G/0,G0,g 111 =ρρ=ρ ). This leads to 1)0,(g 2 −ρ=β . It is assumed that β will remain 
constant throughout the remaining τ since it only depends on the optical system [15]. 
Now, ),(g1 τρ can be calculated for all τ with Eq. 1 using measured ),(g 2 τρ  and calculated 
β. The flow index (αDB) is then considered an unknown parameter in Eq. 3, which is fit 
with the ),(g1 τρ  calculated previously. For each DCS data acquisition sequence, a unique 
flow index is obtained for 785 and 830 nm. Two flow indices are obtained sequentially to 
obtain a complete frame of DCS data acquisitions at two wavelengths. The overall 
process of DCS data acquisition is given in Fig. 3. 
 
2.2 Frequency Domain Spatially Resolved Near-Infrared Spectroscopy for 
Measurement of Optical Properties 
A four-wavelength (690, 750, 780, and 830 nm) FD multi-distance spatially resolved 
spectroscopy instrument, i.e., the Imagent, is incorporated to quantify absolute μa and μs’. 
Only two wavelengths (780 and 830 nm) were chosen so as to match the available DCS 
lasers (785 and 830 nm). Imagent measurements are obtained similar to DCS with semi-
infinite geometry, by emitting NIR light into the tissue through source fibers with 
detector fibers up to a few cm away, both at the tissue surface. The FD Imagent system 
emits light sinusoidally modulated at 110 MHz. Optical fiber arrangement consists of 8 
source fibers (4 per wavelength) placed at four pre-determined distances (2.0, 2.5, 3.0, 
and 3.5 cm) from a detector fiber bundle. The detector fiber is connected to a 
photomultiplier tube (PMT) (see Fig. 2). Utilizing the amplitudes of light signal 
 16
modulation (ac), average (dc), and phase (φ), information can be detected from the 
different source-detector separations (r). It was found that linear relationships exist 
between logarithmic ac, logarithmic dc or φ and the spatial distances through solutions to 
a photon diffusion equation [48]. The slopes (Slac, Sldc, Slφ) of these linear relationships 
can be fit from the multi-distance measurements. From these slopes μa and μs’ can be 
determined at both wavelengths. For the phantom study, by use of homogeneous 
phantoms the different source and detector separations are expected to have minimal 
effect on the measured optical properties despite probing different depths. In the real 
tissue tumor study analysis this effect may be more prominent (see Chapter 3.4).  
In Imagent operation, the fitting solutions mentioned above are not ideal for real 
tissue measurements due to the requirement of iterative calculations. Therefore, a faster 
approximate solution is employed defined by the following equations [57]: 
 ( ) ( ) ( )dc'dc'sadc2 K,DIn,rSlrdcln +μμ=  (4) 
 ( ) ( )ΦΦΦ +ωμμ=Φ KInv,,,rSl ''sa  (5) 
 ( ) ( ) ( )ac'ac'saac2 K,DInv,,,rSlracln +ωμμ=  (6) 
where ω is the angular frequency of the modulation, v is the speed of light in the medium, 
D is the photon diffusion constant ( 's3/1D μ≈ ), KΦ is the relative phase of the source plus 
any phase shifts outside the sample, Kac and Kdc are constants dependent on detector 
sensitivity factors, modulation depth, and source intensity, and In’dc, In’Φ, and In’ac are 
the line intercepts. Only two of the three slopes are required per wavelength to obtain 
corresponding μa and μs’, but using the combination of Slac and SlΦ eliminate influences 
form background light [47]. 
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2.3 Hybrid Instrument Data Acquisition 
The hybrid instrument alternates data acquisition sequentially between DCS and 
Imagent. An individual acquisition sequence begins with DCS activating the first laser 
and collecting data from the autocorrelator. The first laser is then switched off and the 
process is repeated for the second DCS laser. Notification is then sent from DCS to the 
Imagent via a TTL trigger to proceed with an iteration of data acquisition. The Imagent 
activates an individual laser source at the first distance collecting data from the PMT. 
Data is collected similarly for the Imagent laser activated alternately at each distance. The 
Imagent laser is then shut off and each remaining Imagent laser source (at different 
wavelengths) is sequentially activated to acquire data in the same manner before finally 
returning control to the DCS. The notification to DCS signifies the completion of one 
data acquisition cycle, which is then repeated until the end of the measurement. Total 
data acquisition time per frame is ~2.7 s (~1.2 s for each of two DCS wavelengths and 
~0.3 s for Imagent). After the measurement is finished Imagent places AC, DC, and 
Phase information into a .txt file. The .txt file is further analyzed by supplemental 
Imagent processing functions, such as to produce μa and μs’, and saved in a .log file. 
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2.4 Particle Brownian Motion in Liquid Phantoms 
For comparisons with DCS flow indices, Einstein Brownian diffusion coefficients are 
determined for liquid phantoms. Intralipid particles provide Brownian motion within the 
phantoms. This motion is expected to be equivalent to the effective Brownian diffusion 
coefficient (flow index) as measured using DCS [46]. Determination of the phantom 
diffusion coefficient follows calculations per the Einstein-Stokes formula for spherical 
particles suspended in liquid defined as: 
 ηπ= R6
k
D
TB
B  (7) 
where R is the Intralipid spherical particle radius, η is the viscosity of the phantom, T is 
the temperature of the phantom, and kB is the Boltzmann constant [46]. Due to difficulties 
in measuring the Intralipid particle radius, an estimation of 196 nm is used (see Chapter 
2.7). The phantom viscosity is measured with a commercial viscometer (Brookfield, MA, 
USA). The viscosity parameter is reported in units of cP (centipoise), where 1 cP = 1 
mPa·s (millipascal·second) = 0.001 kg·m-1s-1 [58]. Measurement of the phantom 
temperature is obtained via a temperature sensor (Physitemp, NJ, USA) attached near the 
hybrid probe. For further details on acquisition of this data see Chapter 2.6. 
 
2.5 Liquid Phantom Creation 
We follow previously published methods for creating liquid phantoms, but examine 
implementation details thereof here for clarity and re-creation purposes. The composition 
of liquid phantoms consist of India ink (Black India 44201, Higgins, MA, USA), 
Intralipid (30%, Fresenius Kabi, Uppsala, Sweden), and distilled water. Originally 
deionized water was used, but was difficult to obtain and produced similar results to 
 19
distilled water for our purposes. The complete liquid phantom setup can be seen in Fig. 4. 
The phantom solution is contained within a 9607.5 cm3 aquarium (~9.5 L). The hybrid 
fiber-optic probe (see Fig. 2) is positioned on the phantom surface simulating superficial 
tissue measurement configuration of semi-infinite geometry. To keep the probe 
stationary, a custom probe holder was built by a machine shop. The holder maintains the 
probe near the center of the phantom solution, away from aquarium boundaries. 
 
  
Figure 4. Liquid Phantom Setup 
Hybrid instrument (left) and liquid phantom (right) setup including: ~9.5 L glass aquarium (30.5 cm x 21.0 
cm x 15.0 cm), hybrid optical probe with holder, lab stand and Cartesian coordinates oriented for DCS 
source and detector. 
 
A 30% Intralipid solution provides particle Brownian motion, as described by Eq. 7. 
Additionally, it is used to manipulate the phantom reduced scattering coefficient, μs’ 
phantom, while contributing minimally to phantom absorption. The phantom absorption 
x
y z
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coefficient, μa phantom, is manipulated using the India ink with minimal influence on 
phantom scattering. Due to the very high contribution of absorption from pure India ink, 
a solution of 10% ink with 90% distilled water is created. The 10% solution is used rather 
than pure ink to manipulate the μa phantom. Distilled water contributes little to both 
phantom absorption and scattering, allowing for larger phantom volumes to facilitate 
satisfying the semi-infinite geometry model. The subscripts “water”, “ink”, and 
“Intralipid” denote distilled water, 10% ink solution, and 30% Intralipid, respectively. 
Prior to prediction of phantom optical properties, the μa and μs’ of the contributing 
solutions must first be determined. These values will then be used in combination with 
titration equations for predicting the volumes of water, 10% ink solution, and 30% 
Intralipid needed to obtain the phantom optical properties required. 
Intralipid, ink, and water μa. Spectrometer (Beckman Coulter, CA, USA) 
measurements allow derivation of the 10% ink solution absorption coefficient, μa ink. The 
10% ink solution is not within the measurable range of the spectrometer. Thus, for 
absorbance measurements the 10% solution is further diluted to a 0.025% ink solution (of 
ink and water). Multiple samples of the 0.025% ink solution are distributed into 
individual 1 cm path-length cuvettes and scanned by the spectrometer at 780 and 830 nm 
(matching the Imagent source wavelengths). These absorbances are averaged and 
converted to absorption by: μa ink (λ) = ln (10) x Absorbance (λ) [59]. Values for μa water at 
780 and 830 nm are obtained from the literature [60]. As Intralipid is primarily comprised 
of water, it is assumed to have an absorption coefficient equivalent to water, i.e. μa Intralipid 
= μa water. 
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Intralipid, ink, and water μs’. The μs’ of 30% Intralipid is derived from the 
theoretical values for 10% Intralipid. The μs’ of 10% Intralipid is first calculated using a 
Mie theory approximation and subsequently multiplied by a factor of three to obtain the 
μs’ of 30% Intralipid, μs’ Intralipid [59]. The Intralipid particle radius and refractive index 
along with related theory and details are described in the original derivation [61], which 
has been used extensively for quantification of Intralipid-based liquid phantoms [12, 14, 
59, 62, 63]. As there are expected to be no contributions to the phantom scattering by the 
10% ink solution or distilled water both are ignored in calculations, i.e., μs’ ink = μs’ water = 
0 cm-1. 
Liquid phantom μa variation. A list of desired μa and a constant μs’ must first be 
chosen at a specific wavelength for creating phantoms with varied μa (see Chapter 2.6). 
Optical properties at other wavelengths are found later, once the phantom composition 
has been predicted. The available aquarium size is considered the total phantom volume, 
Vphantom. Volumes of distilled water (Vwater), 10% ink solution (Vink), and 30% Intralipid 
(VIntralipid) required to obtain the set of μa and μs’ are then calculated for the initial 
phantom. For our experiments, the initial phantom optical properties at 830 nm are: μa 
phantom (830 nm) = 0.05 cm-1 and μs’phantom (830 nm) = 10 cm-1. Using a titration equation, 
the 10% ink solution volume (Vink) can be determined as follows [59]: 
( ) ( ) ( ) ( ) phantomphantomainkinkainkphantomwatera Vxnm830Vxnm830VVxnm830 μ=μ+−μ  
           (8) 
The volume of 30% Intralipid (VIntralipid) is determined using a similar titration 
equation [59], 
 ( ) ( ) phantomphantom'sIntralipidIntralipid's Vxnm830Vxnm830 μ=μ   (9) 
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The volume of distilled water is simply the remaining volume to be filled, calculated 
by: Vwater = Vphantom – Vink – VIntralipid. The 10% ink solution will be added in equivalent 
amounts each step to increase the phantom μa. Generalizing the titration equation to the 
volume of 10% ink solution to add, addinkV , is given by [59]: 
( ) ( ) ( ) ( )addink1iphantomphantomiaaddinkinka1iphantomphantom1ia VVxnm830Vxnm830Vxnm830 +μ=μ+μ −−−
           (10) 
where i is the step (i.e., i = current step, i-1 = previous step). Notice that the total 
phantom volume for the next step will be the sum of the 10% ink solution volume added 
with the current volume. After the volumes have been determined Eq. 8 and Eq. 9 can be 
used with known volumes and constituent optical properties to predict the μa phantom (λ) 
and μs’ phantom (λ) at other desired wavelengths.  
Liquid phantom μs’ variation. The process for varying the phantom μs’ is like that 
of μa variation, starting with selection of the constant μa and list of μs’ (see Chapter 2.6). 
The initial phantom is created from the volumes of distilled water, 10% ink solution, and 
30% Intralipid as calculated using Eq. 8 and 9. The desired initial phantom optical 
properties are: μa phantom (830 nm) = 0.125 cm-1 and μs’phantom (830 nm) = 4 cm-1. Contrary 
to the μa variation, both 30% Intralipid and 10% ink solution need to be added at each 
step for μs’ variation. The additional 30% Intralipid each step contributes additional 
volume and lowers the phantom absorption. To account for these factors requires 
matching the μa of the added 30% Intralipid to that of the phantom. This will maintain a 
constant phantom μa. The volume of 30% Intralipid to be added (
add
IntralipidV ) is determined 
by the following titration equation [59]: 
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( ) ( ) addIntralipidIntralipid'sphantom1iphantom's Vxnm830Vxnm830 μ+μ −  
( ) ( )addIntralipidphantomiphantom's VVxnm830 +μ=     (11) 
The quantity of 10% ink solution to be added ( addinkV ) is determined by a slightly 
modified form of Eq. 10 [59], 
( ) ( ) ( ) addIntralipidwateraaddinkinkaphantomphantom1ia Vxnm830Vxnm830Vxnm830 μ+μ+μ −  
( ) ( )addIntralipidaddinkphantomphantomia VVVxnm830 ++μ=    (12) 
Once the additional volumes of 10% ink solution and 30% Intralipid are added and 
mixed with the phantom solution, an equivalent volume to that added 
( addink
add
Intralipidremove VVV += ) is removed to maintain probe submersion depth. These 
procedures are repeated for all remaining steps. To predict the optical properties at other 
wavelengths, the percentage of each constituent must first be determined. It is assumed 
the percentages are equivalent in the amount of volume removed as to the entire 
phantom. This allows one to obtain their corresponding volumes at every step. Then Eq. 
8 and 9 are used as is done with μa variation to predict the μa phantom (λ) and μs’ phantom (λ) 
at desired wavelengths. 
 
2.6 Phantom Experimental Protocols 
μa variation. In the first experiment, the μs’ was maintained constant throughout: μs’ 
(830 nm) = 10 cm-1. Conversely, μa was varied in an increasing manner consisting of 
thirteen steps. The absorption range covers µa (830 nm) from 0.05 to 0.20 cm-1 with a 
step size of 0.0125 cm-1 (i.e., µa (830 nm) = 0.05, 0.0625, 0.075, …, 0.20 cm-1). 
Calibration of the Imagent with a phantom of known optical properties is done prior to 
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starting measurements. During calibration, corrections are made accounting for the 
efficiency of optical coupling among the lasers/detector, optical fibers, and phantom [47, 
57]. A liquid phantom of equivalent composition and optical properties as the midpoint 
(step 7) was used for calibration. The initial phantom was created consisting of optical 
properties at the lowest step, i.e., µa (830 nm) = 0.05 cm-1. The hybrid probe with 
temperature sensor was placed onto this phantom and the following actions were taken 
for each of the 13 steps. The volume of 10% ink solution to add was determined as 
detailed in Chapter 2.5. This volume was then added to the liquid phantom via a pipette, 
mixed, and left to settle for 10 minutes while the optical properties and flow stabilized.  
During the 10 minute period three 500 μL samples were extracted from the phantom for 
viscosity measurements. The samples were taken from the right, middle, and left of the 
solution to minimize spatial variations. The pipette sampled from within 1-2 cm of the 
surface to prevent submersion. All lights in the room were switched off or covered with 
black tape. Black plastic was used to cover the phantom setup to reduce any remaining 
ambient light. Hybrid optical measurements (including temperature) were obtained for an 
interval of 5 minutes duration.  
μs’ variation. The second experiment maintained a constant μa throughout: µa (830 
nm) = 0.125 cm-1. The μs’ was increased over a total of thirteen steps. The scattering 
range covers µs’ (830 nm) from 4 to 16 cm-1 with a step size of 1 cm-1 (i.e., µs’ (830 nm) 
= 4, 5, 6, …, 16 cm-1). This experiment immediately followed the μa variation. Prior to 
instantiating this second phase, the μa variation phantom was disposed of and replaced by 
the μs’ variation initial phantom. Alcohol pads were used to clean the probe before 
repositioning it onto the initial phantom. The DCS and Imagent were not shut down 
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between protocols. Two potential difficulties arise with the addition of 30% Intralipid due 
to the amount required: potential reduction in the phantom μa and probe submersion. The 
addition of 10% ink solution with that of the additional 30% Intralipid allows the μa of 
the phantom to be maintained. To prevent probe submersion, after mixing at each step an 
equivalent amount of phantom solution is removed. Hybrid optical, temperature, and 
viscosity measurements were obtained in the same manner as during μa variation. 
 
2.7 Phantom Data Analysis 
For each 5 minute interval, the following parameters were obtained through 
measurements and post-analysis calculations: μa, μs’, temperature, viscosity, and three 
diffusion coefficients (DB’s). Note that in all cases except viscosity, data between 
intervals (i.e., making additions, stirring) is not included in data analysis. Interval 
averages were found for μa and μs’ at both wavelengths (780 and 830 nm) over each 5 
minute interval. Temperature is also averaged over each 5 minute interval. Viscosity 
measurements were obtained at 50, 60, and 100 RPM for each of three samples and 
averaged. The liquid phantom was assumed a Newtonian fluid. The three sample average 
was then calculated to produce the mean viscosity per interval. Using the averaged μa and 
μs’ as known parameters DCS measured g1’s, calculated from Eq. 1 with measured g2, are 
fit using Eq. 3 to produce two distinct DB’s. Subscripts denote which set of optical 
properties (assumed or measured) were used in order to differentiate the two DB’s. For 
assumed optical properties, the averaged µa and µs’ from the middle interval (step 7), i.e., 
µa (830 nm) = 0.125 cm-1 and µs’ (830 nm) = 10 cm-1, are used in calculations of the first 
DCS DB, termed DB-mid. The DB-mid represents the diffusion coefficient without 
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consideration as to any optical property variations. Errors are induced in flow index 
calculations by forcing the varying optical property to be held constant. During early 
intervals the middle interval overestimates µa (first experiment) and µs’ (second 
experiment) while at later intervals it underestimates. Corresponding interval µa and µs’ 
averages are used in calculation of the second DCS DB, termed DB-dynamic. This DB is 
considered the best evaluation of DCS flow index. DB-mid and DB-dynamic are calculated at 
both DCS wavelengths used, 785 and 830 nm. The DCS DB calculations at 785 and 830 
nm utilized the averaged optical property data from the Imagent at 780 and 830 nm, 
respectively. The influence from wavelength mismatch between 780 and 785 nm is 
considered to be minor. The two sets of DCS DB’s, at each wavelength, are calculated 
then averaged over the 5 minute interval. A third DB is calculated by Eq. 7, termed DB-
Einstein, with the three sample averaged viscosity, interval averaged temperature, and 
estimated particle radius. The Intralipid particle radius estimation was found to exhibit 
the least errors between the measured DCS flow indices (DB-dynamic) and calculated DB-
Einstein at the calibration point (step 7).  This estimation, 196 nm, is within the Intralipid 
particle size range as reported in the literatures [14, 61]. 
Figures and tables are used for results presentation to visualize measurement 
variations, optical property influences on DCS flow indices, and differences between 
predicted and measured values. Error bars illustrate standard deviations (SD) and data are 
depicted as mean ± SD. Percentage errors between measured and predicted values were 
calculated and used to characterize measurement errors. Student t-test p-values are 
presented to compare measurement errors, while the significance criterion is p < 0.05. 
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2.8 Head and Neck Tumor Study Protocol and Data Analysis 
The phantom study results provide a general view of errors in flow indices due to 
constant optical properties assumptions. In order to more easily visualize the implications 
of such assumptions on real tissue measurements, in-vivo data from an ongoing tumor 
study is analyzed. A hybrid optical instrument, similar to that in the phantom study, was 
employed in measuring tissue hemodynamic properties of head and neck tumors in 10 
patients. Inclusion was restricted to only those patients with Stage III-IVb Squamous Cell 
Carcinoma of the Head and Neck (SCCHN). Further selection criteria included neck 
lymph nodes that measured greater than 1 cm and were clinically thought to be involved 
by tumor. Subjects completed consent forms and institutional review board (IRB) 
approval was given by the University of Kentucky prior to participation in the study. 
Not all DCS and Imagent laser sources used in the phantom study were available for 
the tumor study and, as a result, some differences are encountered. DCS employed lasers 
at 785 and 854 nm whereas the Imagent had 690 and 830 nm. The best match between 
source wavelengths of the two instruments, for data analysis, was determined to be 854 
nm for DCS and 830 nm for Imagent. Due to the large gap between the other two 
sources, 785 versus 690 nm, they are excluded from this analysis. The Imagent source 
and detector fiber separations are identical as that in the phantom study (i.e., 2.0, 2.5, 3.0, 
and 3.5 cm). Three source and detector separations were achieved with DCS, utilizing 3 
detector fibers at 1.5, 2.4, and 2.8 cm from the bundled source fibers. For the phantom 
study, homogeneity was assumed for all source and detector separations. However, in the 
tumor study our analysis focuses on the 2.8 cm separation from DCS as it is expected to 
be most comparable to the tissue region/depth probed by the Imagent. The handheld 
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probe was placed on the tissue surface at the center of the area identified as tumor node, 
as applicable to the semi-infinite geometry model, and secured in position. DCS flow 
indices and optical property data were acquired for a duration of ~2 minutes. 
Optical properties were obtained by Imagent, as done in the phantom study, and 
averaged over the 2 minute measurement interval for the 10 patients. Calculations with 
four different sets of measured optical properties produced four unique DCS flow indices. 
The true DCS flow index is considered that which is calculated with the true 
corresponding patient μa and μs’ (i.e., averaged Imagent data over 2 minutes), and is 
termed αDB-dynamic. The remaining three DCS flow indices are calculated using the overall 
patient minimum, mean, and maximum optical properties, termed αDB-min, αDB-mean, and 
αDB-max, respectively. These DB estimates are compared with the true flow index, αDB-
dynamic, for determining errors. Error bars in figures correspond to SD, and data are 
presented by interval mean ± SD. 
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CHAPTER 3: RESULTS 
 
Presentation of results is ordered as follows. First, data related to the calculations of 
Brownian diffusion coefficients (DB-Einstein) and DCS flow indices are given for μa 
variation in liquid phantoms (Chapter 3.1). In a similar fashion, these findings from μs’ 
variation are then reported (Chapter 3.2). The next section (Chapter 3.3) summarizes the 
influence of μa and μs’ variations on flow indices and is divided into three subsections: 
the influence of μa and μs’ variations on DB-Einstein, the measurement errors found for μa, 
μs’ and DCS flow indices compared to predicted values, and the influence of inaccurate 
estimations of μa and μs’ on DCS flow indices. Finally, the influence of tissue optical 
properties on DCS blood flow indices of head and neck tumors is presented (Chapter 
3.4). 
 
3.1 μa Variation 
The first experiment performed consists of varying the μa of a liquid phantom while 
maintaining a constant μs’ to evaluate the influences on DCS flow indices. Thirteen steps, 
with a μa step size of 0.0125 cm-1, were carried out over µa (830 nm) from 0.05 to 0.20 
cm-1 with μs’ (830 nm) = 10 cm-1. At 780 nm, the μa will also increase and have constant 
μs’, but manipulations were purposely invoked at 830 nm only. Measurements were 
obtained for thirteen separate 5 minute intervals. These were analyzed post measurement 
producing data sets of mean and SD’s per interval for viscosity, temperature and three 
DB’s. The viscosity, temperature and true flow index, calculated DB-Einstein, are shown in 
Fig. 5 – 7, respectively, with error bars designating the SD’s. Each DB-Einstein (Fig. 7) is 
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calculated with the measured interval temperature (Fig. 6), corresponding viscosity (Fig. 
5), and estimated particle radius (196 nm). 
Raw data and interval means with SD’s (as error bars) of measured and true μa, μs’, 
DB-Einstein, DB-mid, and DB-dynamic during μa variation at the employed wavelengths are 
displayed in Fig. 8 – 14. For raw data figures (Fig. 8, 10, 12, and 13), the black vertical 
lines indicate separation between 5 minute data acquisition intervals and frame numbers 
serve as a generic counter as the data between intervals has been excluded for clarity. To 
quantify measurement errors for the optical properties, predictions using Mie theory 
estimations and spectrometer results are used as true values for comparisons to μs’ and μa, 
respectively. Calculated DB-Einstein is not wavelength dependent and thus is the same for 
comparisons with DCS flow indices, DB-dynamic and DB-mid, at both wavelengths. Averaged 
optical properties at the middle interval [µa (830 nm) = 0.125 cm-1 and µs’ (830 nm) = 10 
cm-1] are used for calculations of DB-mid and from corresponding intervals for DB-dynamic. 
 
Figure 5. Viscosity During μa Variation 
Viscosity as averaged from three samples corresponding to each step, depicted as means ± SD’s (as error 
bars), during μa variation. Small variations can be seen within steps attributable to variations in sample 
measurements. Viscosity during step 2 has larger variations than other steps for reasons unknown, but is 
possibly due to operational error. The variation in viscosity across all steps is relatively low indicating 
stability of this parameter. 
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Figure 6. Temperature During μa Variation 
Temperature as averaged over 5-minute intervals, depicted as means ± SD’s (as error bars), during μa 
variation. Temperature variations within each step are small. An increasing trend is apparent and most 
likely the result of increasing ambient temperature within the confined room during measurements. The 
overall variation is small and the parameter is considered stable. 
 
Figure 7. Brownian Motion During μa Variation 
Stability of particle Brownian motion, with DB-Einstein for corresponding 5-minute intervals, during μa 
variation. The stability of this variable is exhibited with only minor variations. These fluctuations are due to 
the small viscosity and temperature variations governed by Eq. 7. 
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Figure 8. Raw Data of Imagent Measured μa at 780 and 830 nm During μa Variation 
Imagent measured μa at 780 nm (left) and 830 nm (right) acquired from each data acquisition cycle (frame) 
during μa variation. The noise is relatively low at early intervals, but increases significantly near higher μa 
with decreases in Imagent detected intensity. 
 
Figure 9. μa at 780 and 830 nm During μa Variation 
Imagent measured μa, shown as interval means ± SD’s, and μa predicted using spectrometer measurements 
at 780 nm (left) and 830 nm (right) for μa variation. Increases in Imagent measured μa are in agreement with 
spectrometer predictions. The agreement is better at 830 nm which may be due to the detection accuracy of 
Imagent at separate wavelengths. Measurement variations within intervals can be seen to increase with the 
increasing noise shown in Fig. 8. 
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Figure 10. Raw Data of Imagent Measured μs' at 780 and 830 nm During μa Variation 
Imagent measured μs’ at 780 nm (left) and 830 nm (right) acquired from each data acquisition cycle (frame) 
during μa variation. The noise is low at early intervals and continually increases with the addition of ink at 
each step as Imagent detected intensity decreases. The μs’ at both wavelengths are relatively stable 
throughout the measurement. 
 
Figure 11. μs' at 780 and 830 nm During μa Variation 
Imagent measured μs’, shown as interval means ± SD’s, and μs’ predicted from Mie theory approximations 
at 780 nm (left) and 830 nm (right) for μa variation. Small deviations between Imagent measured μs’ and 
Mie theory predictions can be seen, but are within expectations (see Chapters 3.3 and 4.2). Measurement 
variations within intervals can be seen to increase with the increasing noise shown in Fig. 10.  
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Figure 12. Raw Data of DCS Measured DB-dynamic at 785 and 830 nm During μa Variation 
DCS measured DB-dynamic at 785 nm (left) and 830 nm (right) acquired from each data acquisition cycle 
(frame) during μa variation. Noise levels after averaging from four detectors is low for all intervals. A 
slightly increasing trend may be due to the decreases in diffusion applicability from increasing μa compared 
to μs’. 
 
Figure 13. Raw Data of DCS Measured DB-mid at 785 and 830 nm During μa Variation 
DCS measured DB-mid at 785 nm (left) and 830 nm (right) acquired from each data acquisition cycle (frame) 
during μa variation. Noise levels after averaging from four detectors is low for all intervals, the same as for 
DB-dynamic (see Fig. 12). The largely decreasing trend is expected to be due to the lack of accounting for 
changes in the optical properties. 
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Figure 14. DB at 785 and 830 nm During μa Variation 
DCS DB-dynamic and DB-mid, shown as interval means ± SD’s, and Brownian diffusion coefficients, DB-Einstein, 
at 785 nm (left) and 830 nm (right) for μa variation. This figure overlays the DB-Einstein from Fig. 7 with the 
interval means of DCS measured DB-mid and DB-dynamic from Fig. 12 and 13. Deviations between DB-mid 
appear to be much greater than DB-dynamic in comparison to DB-Einstein (true flow index) indicating DB-dynamic as 
the more accurate flow index.  
 
3.2 μs’ Variation 
Results of the μs’ variation experiment are given in the same format as that for μa 
variation. Thirteen steps of increasing μs’ were carried out with a step size of 1 cm-1 
covering µs’ (830 nm) from 4 to 16 cm-1 with constant µa (830 nm) = 0.125 cm-1. The 
viscosity, temperature, and calculated DB-Einstein means with SD’s as error bars are 
displayed in Fig. 15 – 17, respectively. Note that the same DB-Einstein set is used as the true 
flow indices for comparison with both DCS source wavelengths. Raw data and interval 
means of measured μa, μs’, DB-Einstein, DB-dynamic, and DB-mid with SD error bars are shown 
in Fig. 18 – 24 along with predicted μa and μs’ (as done in Chapter 3.1). Raw data figures 
(Fig. 18, 20, 22, and 23) are presented in a similar fashion to Chapter 3.1. 
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Figure 15. Viscosity During μs' Variation 
Viscosity as averaged from three samples corresponding to each step, depicted as means ± SD’s (as error 
bars), during μs’ variation. These measurements exhibit small variations within steps due to sample 
variations, but are stable overall. Step 2 has larger variations for reasons possibly due to operational error. 
 
Figure 16. Temperature During μs' Variation 
Temperature is averaged over 5-minute intervals, depicted as means ± SD’s (as error bars), during μs’ 
variation. Temperature variations within each step are small, but overall stable with a generally increasing 
trend caused from increases in ambient temperature within the confined room throughout measurements. 
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Figure 17. Brownian Motion During μs' Variation 
Stability of particle Brownian motion, with DB-Einstein for corresponding 5-minute intervals, during μs’ 
variation. This variable shows as stable with only minor variations caused by small viscosity and 
temperature variations governed by Eq. 7. 
 
Figure 18. Raw Data of Imagent Measured μa at 780 and 830 nm During μs' Variation 
Imagent measured μa at 780 nm (left) and 830 nm (right) acquired from each data acquisition cycle (frame) 
during μs’ variation. The noise is slightly higher than during μa variation at early intervals, likely due to the 
high Intralipid concentration, increasingly worsening throughout the measurement. The μa is relatively 
stable overall with a small jump occurring from the first and second intervals at 780 nm. This jump may be 
caused by near saturation of the Imagent detectors at the earliest interval.  
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Figure 19. μa at 780 and 830 nm During μs' Variation 
Imagent measured μa, shown as interval means ± SD’s, and μa predicted using spectrometer measurements 
at 780 nm (left) and 830 nm (right) for μs’ variation. The deviations between Imagent measured μs’ and Mie 
theory predictions are minor, but within expectations (see Chapters 3.3 and 4.2). Measurement variations 
within intervals can be seen to increase with the increasing noise shown in Fig. 18. 
 
Figure 20. Raw Data of Imagent Measured μs' at 780 and 830 nm During μs' Variation 
Imagent measured μs’ at 780 nm (left) and 830 nm (right) acquired from each data acquisition cycle (frame) 
during μs’ variation. Noise is low early and increases with each step and the addition of Intralipid which 
decreases the Imagent detected intensity. 
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Figure 21. μs' at 780 and 830 nm During μs' Variation 
Imagent measured μs’, shown as interval means ± SD’s, and μs’ predicted from Mie theory approximations 
at 780 nm (left) and 830 nm (right) for μs’ variation. Increases in Imagent measured μs’ are in agreement 
with Mie theory predictions. The agreement at 780 nm appears better which may be due to the detection 
accuracy of Imagent at separate wavelengths, similar to μa during μa variation (see Fig. 9). Measurement 
variations within intervals can be seen to increase with the increasing noise shown in Fig. 20. 
 
Figure 22. Raw Data of DCS Measured DB-dynamic at 785 and 830 nm During μs' Variation 
DCS measured DB-dynamic at 785 nm (left) and 830 nm (right) acquired from each data acquisition cycle 
(frame) during μs’ variation. Noise levels are low for all intervals with detector averaging. The trend is 
decreasing at early intervals before stabilizing around the fourth and fifth intervals. This is possibly due to 
poor diffusion from a low μs’ compared to μa. 
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Figure 23. Raw Data of DCS Measured DB-mid at 785 and 830 nm During μs' Variation 
DCS measured DB-mid at 785 nm (left) and 830 nm (right) acquired from each data acquisition cycle (frame) 
during μs’ variation. Noise levels are low as was the case for DB-dynamic (see Fig. 22). There is a largely 
increasing trend due to the lack of accounting for changes in the optical properties. 
 
Figure 24. DB at 785 and 830 nm During μs' Variation 
DCS DB-dynamic and DB-mid, shown as intervals means ± SD’s, and Brownian diffusion coefficients, DB-Einstein, 
at 785 nm (left) and 830 nm (right) for μs’ variation. As was done for μa variation, this figure overlays the 
DB-Einstein from Fig. 17 with the interval means of DCS measured DB-mid and DB-dynamic from Fig. 22 and 23. 
Deviations between DB-mid are significantly greater than DB-dynamic in comparison to DB-Einstein (true flow 
index) indicating DB-dynamic as the more accurate flow index. 
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3.3 Quantification of μa and μs’ Influences on Flow Indices 
Influence of μa and μs’ variations on DB-Einstein. Variations in phantom optical 
properties are examined to determine any potential influences on DB-Einstein. Using the 
data displayed in Fig. 5 – 7 and 15 - 17, the means, SD’s, and coefficients of variation 
(CV) were calculated over the entire μa and μs’ variation experiments for viscosity, 
temperature, and DB-Einstein. The results are shown in Table 1, with experiments separated 
into different columns. No major influences are noticeable on DB-Einstein or related 
parameters with CV’s less than 2.2% for all three in both optical property variations. 
With this knowledge, the DB-Einstein is considered viable as the true flow index for 
determining measurement errors in DCS flow indices. 
 
Table 1. Mean ± Standard Deviation and Coefficients of Variation of Viscosity, Temperature, and 
Brownian Motion 
Variables 
μa variation  μs’ variation 
Mean ± SD CV  Mean ± SD CV 
Viscosity (cP) 0.98 ± 0.02 1.54%  0.96 ± 0.02 2.12% 
Temperature (°C) 18.61 ± 0.20 1.05%  18.80 ± 0.12 0.64% 
DB-Einstein (cm2/s) 1.05E-08 ± 1.65E-10 1.57%  1.07E-08 ± 2.25E-10 2.11% 
 
Mean measurement errors in μa, μs’ and DCS flow indices. Measurements errors 
are described using absolute percentage errors defined as: 
 %100xTrue
TrueEstimate
ErrorPercentageAbsolute
−=   (13) 
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In the case of DCS flow indices, DB-Einstein is considered the true flow index whereas DB-
dynamic and DB-mid are estimates. Estimated μa and μs’ are those averaged from 
measurements while true values are from spectrometer and Mie theory predictions, 
respectively. Using the estimated and true data (shown in Fig. 9, 11, 14, 19, 21, and 24) 
over the complete range of μa and μs’ variations, measurement errors were calculated and 
their means ± SD’s are shown in Table 2. P-values are also shown for 2-sample unequal 
variance, two-tailed Student t-tests between mean measurement errors at the wavelengths 
used. Significant differences are denoted with a * prefix when p-values are less than 0.05. 
Measurement errors for μa and μs’ are less than 6% for both experiments and sets of 
wavelengths. DCS flow indices, however, exhibit some discrepancies amongst their 
measurement errors. Errors in DB-mid are overall higher than those of DB-dynamic, indicating 
optical properties influence in DCS DB calculations. Variations in μs’ appear to contribute 
a greater influence on flow index errors than μa variations, as identified by DB-mid errors 
up to 12.89% during μa variation and 49.63% during μs’ variation. Student t-test results 
identified significant differences between mean measurement errors at 780 and 830 nm 
for μa during μa variation (p = 0.01) and μs’ during μs’ variation (p = 0.04). Detection 
accuracy of the Imagent at the different wavelengths is thought to be the greatest 
attributor to these differences. No other significant differences were found between the 
mean measurement errors at both wavelengths. 
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Table 2. Imagent/DCS Measurement Percentage Errors at 780/785 nm (shaded) and 830/830 nm 
(non-shaded) 
Variables 
 μa variation (Absolute % Error)  μs’ variation (Absolute % Error) 
 Mean ± SD p-value  Mean ± SD p-value 
μa 
780 nm  3.39 ± 3.07 
*0.01 
 1.86 ± 1.15 
0.23 
830 nm  0.84 ± 0.95  2.86 ± 2.69 
μs’ 
780 nm  1.93 ± 1.23 
0.54 
 3.14 ± 2.66 
*0.04 
830 nm  1.60 ± 1.50  5.29 ± 2.27 
DB-dynamic 
785 nm  5.52 ± 3.69 
0.28 
 5.84 ± 10.73 
0.83 
830 nm  4.02 ± 3.30  6.58 ± 6.16 
DB-mid 
785 nm  12.89 ± 12.00 
0.64 
 49.63 ± 31.51 
0.81 
830 nm  10.89 ± 8.99  46.76 ± 27.44 
* p-values < 0.05      
 
For both experiments, Student t-tests were also used for comparisons between the 
mean measurement errors of DB-mid and DB-dynamic, within the same wavelengths, as shown 
in Table 3. Significant differences are determined and noted similarly as done in Table 2. 
It is readily seen that DB-mid and DB-dynamic are not equivalent by the significant (although 
for 785 nm during μa variation it is borderline) differences found for both wavelengths 
and experiments. Additionally, DB-dynamic is considered more accurate as it provides less 
measurement errors (see Table 2). As similarly suggested from Table 2, the μs’ influence 
on DCS flow indices is greater than μa as indicated by much lower p-values during μs’ 
variation. 
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Table 3. P-values for Comparisons of the Mean Measurement Errors Between DCS Flow Indices 
Calculated with Dynamic Vs. Assumed Constant Optical Properties 
DB-dynamic vs. DB-mid μa variation (p-value) μs’ variation (p-value) 
785 nm 0.0525 *0.0003 
830 nm *0.0205 *0.0002 
* p-values < 0.05   
 
Influence of μa and μs’ variations on DCS flow index. Percentage errors (not 
absolute) are used to visualize the influences of the individual optical properties on flow 
indices, defined by the following equations:  
 %100xError%
dynamica
dynamicamida
a
−
−−
μ
μ−μ=μ   (14) 
 %100x'
''
'Error%
dynamics
dynamicsmids
s
−
−−
μ
μ−μ=μ   (15) 
 %100xD
DD
DError%
dynamicB
dynamicBmidB
B
−
−− −=   (16) 
The estimates for these errors are the assumed optical properties (middle-interval) and 
subsequent DB-mid per interval. The true values are the averaged optical properties 
measured by Imagent (dynamic) and subsequent DB-dynamic per interval. Resulting 
percentage errors in DCS DB due to inaccurate estimations of optical properties are 
overlaid for both wavelengths and experiments in Fig. 25. Note that errors in μa are 
during μa variation and those in μs’ during μs’ variation. In agreement with results thus far 
the μs’ shows a larger influence on DCS flow indices, as visible by the wider range of DB 
percentage errors, than μa. The trends in errors for μa and μs’ with those in DB also differ. 
Overestimation and underestimation of μa result in overestimation and underestimation in 
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DCS DB. On the contrary, μs’ overestimation and underestimation lead to DB 
underestimation and overestimation. Both wavelengths display analogous behavior and 
are in good agreement. 
 
 
Figure 25. DCS Flow Index Errors Due to Inaccurate Optical Property Estimations 
Inaccurate estimations (percentage errors) of μa and μs’ result in corresponding percentage DB errors 
between DB-dynamic and DB-mid for both wavelengths. 
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3.4 Influence of Tissue Optical Properties on Head/Neck Tumor Blood Flow Index 
Ten patients with head and neck tumors, measured for hemodynamic information, 
have their DCS flow indices evaluated for optical property influences. The resulting 
mean optical properties over patients are: μa (830 nm) = 0.12 ± 0.03 cm-1 and μs’ (830 
nm) = 7.80 ± 2.64 cm-1. The means ± SD’s (error bars) of tumor μa and μs’ are shown in 
Fig. 26 and 27, respectively. Red and blue dots denote the overall patient maximum and 
minimum optical properties, respectively. Patient blood flow indices (αDB-dynamic, αDB-min, 
αDB-mean, and αDB-max) along with percentage errors thereof (aside from αDB-dynamic) are 
given in Fig. 28 and 29. Note that the assumption of α = 1 from phantom experiments is 
no longer correct as the real tissue consists of both static and dynamic scatterers. 
Diffusion coefficient percentage errors are calculated using Eq. 16 by replacing the 
phantom study estimate, DB-mid, with the corresponding tumor study estimates αDB-min, 
αDB-mean, and αDB-max. Also, the true flow index DB-dynamic, calculated using Imagent 
measured optical properties, from the phantom study is replaced in Eq. 16 by the 
equivalent tumor study true flow index, αDB-dynamic. This produces percentage errors for 
each flow index estimate for each patient (see Fig. 29).  
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Figure 26. Tumor μa at 830 nm 
Imagent measured μa, shown as means ± SD’s, obtained at 830 nm from tumor region for 10 subjects with 
head and neck tumors during tumor study. Large variations can be seen to exist between the 10 subjects. 
 
 
Figure 27. Tumor μs' at 830 nm 
Imagent measured μs’, shown as means ± SD’s, obtained at 830 nm from tumor region for 10 subjects with 
head and neck tumors during tumor study. Similar to μa in Fig. 26, large variations also exist in μs’ between 
the 10 subjects. 
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Figure 28. Tumor Flow Indices at 854 nm 
DCS flow indices measured by DCS, shown as means ± SD’s, obtained at 854 nm from tumor region for 10 
subjects with head and neck tumors and calculated using 830 nm optical properties during tumor study. 
Patients are listed in order of increasing αDB-dynamic (854 nm). The underestimation of optical properties 
(αDB-min) overestimates the flow indices whereas overestimating optical properties (αDB-max) underestimates 
flow indices. These trends agree with phantom study results of a larger influence from μs’. 
 
Figure 29. Tumor Flow Index Errors 
Percentage errors in DCS flow indices at 854 nm from tumor region for 10 subjects with head and neck 
tumors. DCS flow indices αDB-min, αDB-mean, and αDB-max are considered estimates with αDB-dynamic as true 
flow indices for patients. The errors are shown to increase substantially with inaccuracies in optical 
properties (see Fig. 26 and 27).  
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To ease identification of differences in patient DCS flow index trends using the 
diverse optical properties sets, they are ordered by increasing αDB-dynamic (true flow 
index). A black line denotes the true flow indices data. Note that the patient numbers 
depicted represent indices for trend illustration and are not related to those corresponding 
to the actual measurement sequence. After this ordering, trend changes when calculating 
flow indices without the true optical properties can be viewed (Fig. 28). When the μa and 
μs’ are inaccurately estimated (αDB-min, αDB-mean, and αDB-max), the trends do not agree 
with the true flow index trend (αDB-dynamic). The αDB estimates result in a wide range of 
percentage errors: αDB-min from -8.07 to 278.15%, αDB-mean from -39.48 to 149.01%, and 
αDB-max from -70.26 to 22.59%. The tumor study data is consistent with expectations 
from phantom study results with μs’ variation appearing to play a greater role than μa in 
DCS flow index errors. From Fig. 28, the consequential overestimation and 
underestimation of blood flow indices are opposite of those of μs’ variation, as seen in 
Fig. 25. 
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CHAPTER 4: DISCUSSION AND CONCLUSIONS 
 
This chapter begins with discussion on the influences of μa and μs’ variations on DB-
Einstein (Chapter 4.1). Findings related to measurement errors in μa, μs’ and DB-dynamic are 
then examined (Chapter 4.2). Next, the flow index errors due to the assumption of optical 
properties are discussed (Chapter 4.3). A comparison is then provided between the in-
vivo tumor study data and phantom study results (Chapter 4.4). Finally, conclusions from 
this study are given (Chapter 4.5). 
 
4.1 μa and μs’ Variation Influences on DB-Einstein 
The Brownian motion of spherical particles, DB-Einstein, from the Intralipid solution in 
liquid phantoms is calculated from the Einstein-Stokes formula (Eq. 7). This movement is 
calculated based on the liquid phantom temperature, spherical particle radius, and 
viscosity. The temperature has only small variations during both phantom experiments 
(see Table 1, Fig. 6, and Fig. 16), with CV < 1.1%. Due to the ~4.5 hour duration of each 
experiment, a general increase in ambient and thus phantom temperature is expected. 
This increase includes heat from running equipment within the small, confined room. The 
particle radius is assumed to be relatively constant during both experiments, with 
Intralipid provided from the same batch supply. Only minor variations in viscosity are 
evident, with CV < 2.2% for both experiments (see Table 1, Fig. 5, and Fig. 15). These 
variations may be the result of the viscometer sensitivity at measurements near the 
bottom of its range (0.2 cP) and minor sample-to-sample variations. The Newtonian fluid 
assumption is determined acceptable as the samples measured at three separate RPMs 
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showed small variation. Because of the stability of viscosity and temperature 
measurements as well as the assumed constant particle radius, DB-Einstein is also expected 
to be constant. This is found to be the case as is seen in Fig. 7 and 17 and with CV < 
2.2% for DB-Einstein from Table 1.  
The addition of ink and Intralipid solutions during μa and μs’ variation, respectively, 
are not parameters expected to contribute to variations in DB-Einstein. Ink solution should 
have no particles undergoing Brownian motion. On the other hand, Intralipid solution 
does contain particles undergoing Brownian motion, but this motion is not anticipated to 
change during measurement. Additions of Intralipid provide more scatterers undergoing 
Brownian motion, but the particle motion is equivalent for all. The ratio of moving to 
total scatterers (α) should also remain unchanged (α = 1) given that only the dynamic 
particles from Intralipid are scatterers. The viscosity of ink and Intralipid solution is, as 
mentioned, primarily water and variations thereof should not result in changing the 
phantom viscosity. Similarly, the ink and Intralipid solutions were at room temperature at 
the time of the experiments, just as the liquid phantom, having little influence on 
temperature variations. From Fig. 5-7, 9, 15-17, and 21 the liquid phantom optical 
properties exhibit independence from viscosity, temperature and DB-Einstein. With the 
optical property independence and DB-Einstein stability, it is therefore considered 
reasonable to use as the true flow index for liquid phantom spherical particle motion. 
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4.2 Measurement Errors of μa, μs’, and DB-dynamic 
From Fig. 9, 11, 19, and 21 the utilization of ink and Intralipid solutions for 
manipulating μa and μs’, respectively, is validated. The incremental addition of ink 
solution results in a linear increase in measured μa with relative stability of μs’ at both 
wavelengths, as expected. Similarly, Intralipid solution linearly increases only μs’ at both 
wavelengths. These measured optical properties were also found to be in good agreement 
with the spectrometer and Mie theory predictions. Variation patterns in Imagent optical 
property measurements may have been influenced by calibration at the midpoint: μa (830 
nm) = 0.125 cm-1, μs’ (830 nm) = 10 cm-1.  
Measurement errors in μs’ were less than 6% (see Table 2) for both wavelengths and 
experiments comparable to the literature using Mie theory estimation (see Chapter 2.7) 
[61]. Overall, average measurement errors for μa/μs’ are minimal with less than 4%/6% 
during μa/μs’ variations. Previous studies experienced measurement error levels in this 
range as well using frequency-domain spatially resolved NIRS [47, 48]. In comparing 
optical property measurement errors at 780 and 830 nm, significant differences were 
determined for μa during μa variation and μs’ during μs’ variation. The detection accuracy 
of the Imagent at separate wavelengths is most likely the cause of such significance. No 
significant differences were found between DB-dynamic measurement errors at 785 and 830 
nm. These DB-dynamic errors averaged less than 7%, comparable to those of optical 
properties (less than 6%), for both wavelengths and experiments. This likeness implies 
optical property influences on DCS DB. 
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4.3 Resulting DB Errors from Optical Property Assumptions 
Inaccurate estimations of μa and μs’ both produced higher DB measurement errors 
(DB-mid) than in comparison with the true measurements (DB-dynamic). From Table 2, DB-mid 
errors were ~13% for μa variation, ~50% for μs’ variation, and only ~7% for DB-dynamic in 
both cases. From Table 3, Student t-tests compliment this lack of resemblance between 
measured and true DB by their significant differences. Comparisons between DB-mid errors 
due to the influence of μa and μs’ variations further extend this conclusion to include that 
μs’ is a greater contributor than μa. This is elicited by the higher DB-mid measurement 
errors during μs’ variation (Table 2), great differences in calculated p-values (Table 3), 
and larger range of DB percentage errors due to inaccurate estimations of μs’ (Fig. 25). 
The phase shifts of light due to dynamic scatterers collectively induce the light speckle 
fluctuations. As DCS flow indices are derived from these fluctuations it is expected that 
errors be more exaggerated by inaccurate scattering estimations. Coupling much larger 
scattering over absorption (i.e., μs’ >> μa) in the liquid phantoms and biological tissues 
with the definition of K2 (see Eq. 3) and the μs’2 term further support is given to μs’ 
having more significance than μa. Wavelengths were not determined to be a decisive 
parameter in DB measurement errors due to optical property assumptions. During both 
experiments, no significant difference was found between DB-dynamic and DB-mid at 785 and 
830 nm (Table 2) and their trends were nearly identical as seen in Fig. 25. Due to the 
closeness of the wavelengths employed, more information may be exposed by choosing a 
wider range. 
Further disparity between the influences of μa and μs’ variations on DCS flow index 
errors exists within their related trends (see Fig. 14, 24, and 25). Overestimated and 
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underestimated μa produces overestimated and underestimated DB, respectively. 
Conversely, overestimated and underestimated μs’ produces underestimated and 
overestimated DB, respectively. By examination of the boundaries of our tested optical 
property inaccuracies (Fig. 25), the largest expected deviations in DCS flow indices can 
be estimated. Overestimating/underestimating μa by up to ~ +150%/-40% produced DB 
percentage errors up to ~ +40%/-20%. Overestimating/underestimating μs’ by up to ~ 
+175%/-35% produced DB percentage errors up to ~ -80%/+110%. The phantom 
properties chosen for calibration may have influence over the optical properties 
estimation errors. 
 
4.4 In-vivo Tumor Study Data in Comparison to Phantom Study Results 
Optical property variations were large between the patients in the head and neck 
tumor study (see Fig. 26 and 27). This scenario proves useful for analyzing real-tissue 
implications of the phantom study results. The optical properties of patients covered: μa 
(830 nm) from 0.07 to 0.16 cm-1 and μs’ (830 nm) from 5.35 to 13.1 cm-1. These 
properties are within the same range as those tested in the phantom experiments. The 
trends in αDB, resulting from calculations with the different optical property sets, are in 
agreement with conclusions from the phantom study. Overestimating/underestimating the 
μa and μs’ (using maximum and minimum) produce underestimation/overestimation of 
the DCS flow index (αDB-max and αDB-min). Thus, the variations in μs’ appear to be the 
greater factor in influencing αDB errors than that of μa. Depending on the optical 
properties assumed, the errors in αDB ranged from ~ -70% up to ~ +280%. Comparisons 
are also made between the estimated αDB (αDB-min, αDB-mean, and αDB-max) trends and the 
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true (αDB-dynamic). It is apparent that inaccurate optical property assumptions will alter the 
patient order based on increasing αDB and potentially any subsequent conclusions made 
from this data. Invalid conclusions in similar studies may result from this lack of 
consideration into optical property influences on DCS flow indices. 
 
4.5 Conclusions 
DCS technology has provided deep tissue blood flow measurements in an increasing 
field of applications thanks to its noninvasive nature and fast data acquisition capabilities. 
Increasing in concert with these developments are the necessities of ensuring the proper 
operation and application of the technology. This includes investigating errors that are 
potentially encountered in measurements, notably the assumption of constant optical 
properties, μa and μs’. DCS measurements are described by the extension of light 
scattering techniques into the diffusive regime of deep tissue, resulting in a correlation 
diffusion equation. DCS blood flow indices stem from a solution to this equation which 
includes the parameters of tissue μa and μs’. With the advent of a hybrid optical 
instrument developed by our lab, we can now measure tissue optical properties and blood 
flow simultaneously. By also incorporating liquid phantom creation techniques to control 
simulated tissue optical properties and flow, investigation of optical property influences 
on DCS flow indices is now possible. The Brownian diffusion coefficient produced by 
the Einstein-Stokes formula for particles in liquid was found applicable and usable as the 
true flow index in comparison to DCS flow indices. The particle motions in the liquid 
phantoms were determined to be independent of variations in the optical properties. 
Although inaccurate estimations of both μa and μs’ produced errors in DCS flow indices 
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larger than that when using true values, μs’ was found to have a more substantial 
influence. This influence was not identified as being dependent on wavelengths 
employed. Therefore, the concurrent measurement of tissue optical properties and DCS 
flow indices is required within studies encountering significant μa and μs’ variations to 
accurately determine tissue blood flow. The examination of a head and neck tumor study 
elucidate the possible consequences of ignoring the optical property variations in real 
tissue measurements.  
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CHAPTER 5: SUMMARY AND PERSPECTIVES 
 
In summary of this research study, I have provided a quantified generalization of the 
influences of inaccurate estimations in optical properties on diffuse correlation 
spectroscopy blood flow measurements by means of liquid phantoms and in-vivo 
analysis. The recent integration by our lab of the Imagent and dual-wavelength DCS 
flow-oximeter into a hybrid instrument has enabled the ability to carry out this 
investigation. The design and completion of this study included my contributions to 
several facets of operation. These contributions consist of the unique phantom study 
experimental design (Chapter 2.6), determination of ideal hybrid instrument setup 
(Chapter 2.1 – 2.3), details of liquid phantom composition, measurement equipment and 
facilitation into our lab (Chapter 2.5), incorporation of measurement errors utilizing 
Brownian motion and theoretical predictions (Chapter 2.4), exemplification of 
generalized DCS flow errors through real tissue tumor study analysis (Chapter 2.8), and 
general methods of data analysis (Chapter 2.7). The results of this study have also been 
peer reviewed and published [64]. 
The experimental design of this phantom study was found capable of adequately 
evaluating the influences of the optical properties on DCS flow indices. The approach 
taken in this study sought to minimize variations other than the optical properties. The 
usage of our hybrid instrument performed as expected without requiring complex 
modifications or alterations. This was an important facet as this instrument is a means of 
avoidance into the errors posed by inaccurate optical property estimations. To further this 
study, an alternative approach would be to analyze Eq. 1 and 3 and determine the 
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influences of optical property variations with varying parameters, which may be the 
subject of future work. However, it is expected that without the knowledge of tissue 
optical properties such extensive quantification may not provide useful results. 
The optimal hybrid instrument setup was determined from the following factors. It is 
expected that DCS flow indices obtained at different wavelengths provide equivalent 
flow information. To evaluate this aspect, 785 and 830 nm wavelengths were used. 
Originally, a long coherence length CW NIRS 690 nm laser was attempted instead of 785 
nm, but due to technical circumstances was unavailable for this study. Utilizing different 
laser source wavelengths for both Imagent and DCS may extend the applicability of the 
results since no wavelengths at the low end of the NIR range were successfully 
incorporated (i.e., ~650 nm). The next factor of interest is maintaining an optimal SNR 
for both the Imagent and DCS equipment. The gain for the Imagent PMT was set at as 
high as possible (without saturation) from the initial phantoms and was not adjusted 
during each experiment. The source-detector separations and fiber orientation of the 
Imagent probe were fixed and not deemed necessary for modification. For the DCS 
system, the detector fibers were bundled and set at an equivalent source-detector 
separation of 1.5 cm. This distance was chosen due to its compliance with diffusion 
theory and adequate SNR. The SNR was increased through the averaging of the signal 
from the four detectors. The range of optical properties chosen also may affect the SNR 
and will be described shortly. The correlation time of DCS was found to be adequate in 
detecting the motion of Intralipid particles during both μa and μs’ variations. The Imagent 
averaged 10 data acquisitions per one frame and DCS about 25 per frame (at both 
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wavelengths). These averaging parameters were determined to provide sufficiently stable 
measurements from the hybrid instrument. 
There are several options currently available for creating tissue-like phantoms for 
NIR optical experimentation. Liquid phantoms were chosen over solid phantoms as they 
are typically easier to create and manipulate. In addition, there is no inherent flow in solid 
phantoms which would require additional design considerations. The liquid phantoms 
comprised of Intralipid, distilled water, and India ink proved capable of our needs thanks 
to their simplicity and versatility. For future studies, modifications to the liquid phantom 
flow can be induced using methyl cellulose or glycerin to evaluate optical property 
influences at different absolute DCS flow indices. However, the addition of these 
elements may have the undesirable effect of also altering the phantom viscosity and 
optical properties. The constituents were readily accessible without significant overhead 
and cost with Intralipid requiring the most effort to obtain. To maintain adequate SNR, 
the optical property ranges in this study were limited. More expansive ranges were tested 
but produced unreliable and unstable results. In the future, creating liquid phantoms with 
a broader range of μa and μs’ can test the expansion of current conclusions to a greater 
variety of tissue types. The container size (aquarium) was chosen for adequate distance 
from the probe to the sides such that small variations in position did not result in 
interference due to boundaries. The custom probe holder was designed and put into a 
schematic prior to machining by the University of Kentucky machine shop. It was 
designed to be incorporated with the lab stand available providing stability and axial and 
longitudinal positioning. 
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Measurement errors for the DCS and Imagent were determined based on previous 
studies to differentiate actual optical property influences on DCS flow indices and those 
resulting from other factors. This includes the liquid phantom preparations and 
measurement variations. The methods for expected value predictions were advantageous 
in that they have already been discussed and used elsewhere allowing for quick 
implementation into our experimental design. Brownian motion for spherical particles in 
liquid is used for comparison with DCS. Spectrometer and Mie theory are used for 
comparison with the Imagent measurements. The measurements of viscosity and 
temperature related to Brownian motion required testing several apparatus setups. For 
viscosity, a spindle viscometer was tested but had inadequate range due to the low 
viscosity of distilled water, India ink, and Intralipid solutions. A cone-plate viscometer 
with better low viscosity accuracy was purchased and performed adequately. No 
continuous viscosity data could be acquired due to the induced motion of pumping liquid 
phantom solution through the viscometer. The current study employs all solutions and 
liquid phantoms at ambient temperature. This method provided the most stable 
temperature over other methods such as immersing the aquarium into a larger water filled 
container temperature controlled by an immersion circulator. More than one spectrometer 
was tested in the determination of the India ink absorption coefficient: a 96-well plate 
reader (Biotek), Jaz (Ocean Optics), and the Beckman Coulter as reported. Results were 
comparable between the three, but the Beckman Coulter device was chosen due to 
availability and speed of usage. 
The tumor study required analyzing the hybrid equipment already in usage for that 
study and reasonably comparing it to the phantom study. There is inherently greater 
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difficulty and complexity involved in in-vivo tissue optical property and flow 
measurements. Multiple DCS source-detector separations and wavelengths were used for 
the head and neck tumor measurements. To properly attribute the optical property 
influences on DCS flow indices the depth chosen was matched as closely as possible to 
that of the Imagent. Although the tissue is assumed homogeneous for the purposes of the 
theoretical models used, the best agreement between regions probed by the two systems 
was chosen. The optical properties of the patients were within the range used in the 
phantom study and it is expected that these will be similar for other tissue types, but a 
holistic representation is beyond the scope of this study and should be determined based 
on the context. More variations in absolute DCS flow indices were expected due to 
anatomical and other subject differences. The agreement with the phantom study results 
provides further insight as to the applicability of the generalized results into in-vivo 
measurements. 
To facilitate data analysis, a custom Matlab program was written to calculate DCS 
flow using various sets of optical properties and variations. Only those flows 
incorporating dynamic and constant property sets were included in this paper. This was 
done to simplify the analysis and provide a less complex, but more usable realization of 
the results. Data had to be extracted from the different files produced by the DCS and 
Imagent for processing. A robust program was written automating data analysis while 
providing control such as wavelengths used, source detector separations and processing 
methods (constant vs. dynamic optical properties). The creation of correlation curve 
figures each frame requires significant hard drive space which should be considered if 
saving is desirable. The method of analysis using averaged optical properties over the 
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intervals was determined acceptable as exhibited by measurement stability. However, in 
real tissue measurements, transient fluctuations in optical properties can occur and 
averaged properties may not be applicable. 
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